Psilocybin is moving deeper into depression research, but the evidence still comes with limits
A new review of 15 clinical trials adds to evidence that psilocybin may help treat depression, especially for patients not well served by standard therapies, while underscoring how early the field still is.
- Researchers reviewed 15 clinical trials testing psilocybin for depression.
- The analysis was published in Nature Mental Health.








